Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer.

Currey N, Jahan Z, Caldon CE, Tran PN, Benthani F, De Lacavalerie P, Roden DL, Gloss BS, Campos C, Bean EG, Bullman A, Reibe-Pal S, Dinger ME, Febbraio MA, Clarke SJ, Dahlstrom JE, Kohonen-Corish MRJ.

Cell Mol Gastroenterol Hepatol. 2019;7(4):819-839. doi: 10.1016/j.jcmgh.2019.01.009. Epub 2019 Mar 2.

2.

Microsatellite Instability in Mouse Models of Colorectal Cancer.

Currey N, Daniel JJ, Mladenova DN, Dahlstrom JE, Kohonen-Corish MRJ.

Can J Gastroenterol Hepatol. 2018 Mar 1;2018:6152928. doi: 10.1155/2018/6152928. eCollection 2018.

3.

Screening for ROS1 gene rearrangements in non-small-cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target.

Selinger CI, Li BT, Pavlakis N, Links M, Gill AJ, Lee A, Clarke S, Tran TN, Lum T, Yip PY, Horvath L, Yu B, Kohonen-Corish MR, O'Toole SA, Cooper WA.

Histopathology. 2017 Feb;70(3):402-411. doi: 10.1111/his.13076. Epub 2016 Nov 15.

4.

Alterations of MET Gene Copy Number and Protein Expression in Primary Non-Small-Cell Lung Cancer and Corresponding Nodal Metastases.

Tran TN, Selinger CI, Kohonen-Corish MR, McCaughan B, Kennedy C, O'Toole SA, Cooper WA.

Clin Lung Cancer. 2016 Jan;17(1):30-8.e1. doi: 10.1016/j.cllc.2015.08.002. Epub 2015 Aug 18.

PMID:
26395411
5.

HIF1α deficiency reduces inflammation in a mouse model of proximal colon cancer.

Mladenova DN, Dahlstrom JE, Tran PN, Benthani F, Bean EG, Ng I, Pangon L, Currey N, Kohonen-Corish MR.

Dis Model Mech. 2015 Sep;8(9):1093-103. doi: 10.1242/dmm.019000. Epub 2015 Jul 16.

6.

Role of Red Meat and Resistant Starch in Promutagenic Adduct Formation, MGMT Repair, Thymic Lymphoma and Intestinal Tumourigenesis in Msh2 -Deficient Mice.

Winter JM, Hu Y, Young GP, Kohonen-Corish MR, Le Leu RK.

J Nutrigenet Nutrigenomics. 2014;7(4-6):299-313. doi: 10.1159/000381675. Epub 2015 May 27.

7.

Proteogenomic Analysis Identifies a Novel Human SHANK3 Isoform.

Benthani F, Tran PN, Currey N, Ng I, Giry-Laterriere M, Carey L, Kohonen-Corish MR, Pangon L.

Int J Mol Sci. 2015 May 19;16(5):11522-30. doi: 10.3390/ijms160511522.

8.

MCC inhibits beta-catenin transcriptional activity by sequestering DBC1 in the cytoplasm.

Pangon L, Mladenova D, Watkins L, Van Kralingen C, Currey N, Al-Sohaily S, Lecine P, Borg JP, Kohonen-Corish MR.

Int J Cancer. 2015 Jan 1;136(1):55-64. doi: 10.1002/ijc.28967. Epub 2014 May 27.

9.

KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.

Kohonen-Corish MR, Tseung J, Chan C, Currey N, Dent OF, Clarke S, Bokey L, Chapuis PH.

Int J Cancer. 2014 Jun 15;134(12):2820-8. doi: 10.1002/ijc.28619. Epub 2013 Dec 6.

10.

Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer.

Al-Sohaily S, Henderson C, Selinger C, Pangon L, Segelov E, Kohonen-Corish MR, Warusavitarne J.

Histopathology. 2014 Aug;65(2):155-63. doi: 10.1111/his.12295. Epub 2014 May 12.

PMID:
24118100
11.

Sulindac activates NF-κB signaling in colon cancer cells.

Mladenova D, Pangon L, Currey N, Ng I, Musgrove EA, Grey ST, Kohonen-Corish MR.

Cell Commun Signal. 2013 Oct 1;11:73. doi: 10.1186/1478-811X-11-73.

12.

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer.

Tran TN, Selinger CI, Kohonen-Corish MRJ, McCaughan BC, Kennedy CW, O'Toole SA, Cooper WA.

Lung Cancer. 2013 Sep;81(3):462-467. doi: 10.1016/j.lungcan.2013.05.015. Epub 2013 Jun 24.

PMID:
23806793
13.

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

Yip PY, Yu B, Cooper WA, Selinger CI, Ng CC, Kennedy CW, Kohonen-Corish MR, McCaughan BC, Trent RJ, Boyer MJ, Kench JG, Horvath LG, O'Toole SA.

J Thorac Oncol. 2013 Apr;8(4):408-14. doi: 10.1097/JTO.0b013e318283558e.

14.

Beyond the genomics blueprint: the 4th Human Variome Project Meeting, UNESCO, Paris, 2012.

Kohonen-Corish MR, Smith TD, Robinson HM; delegates of the 4th Biennial Meeting of the Human Variome Project Consortium.

Genet Med. 2013 Jul;15(7):507-12. doi: 10.1038/gim.2012.174. Epub 2013 Jan 17.

PMID:
23328891
15.
16.

Loss of heterozygosity of the Mutated in Colorectal Cancer gene is not associated with promoter methylation in non-small cell lung cancer.

Poursoltan P, Currey N, Pangon L, van Kralingen C, Selinger CI, Mahar A, Cooper WA, Kennedy CW, McCaughan BC, Trent R, Kohonen-Corish MR.

Lung Cancer. 2012 Aug;77(2):272-6. doi: 10.1016/j.lungcan.2012.04.001. Epub 2012 Apr 26.

PMID:
22542170
17.

The PDZ-binding motif of MCC is phosphorylated at position -1 and controls lamellipodia formation in colon epithelial cells.

Pangon L, Van Kralingen C, Abas M, Daly RJ, Musgrove EA, Kohonen-Corish MR.

Biochim Biophys Acta. 2012 Jun;1823(6):1058-67. doi: 10.1016/j.bbamcr.2012.03.011. Epub 2012 Mar 28.

18.

Mutated in colorectal cancer protein modulates the NFκB pathway.

Sigglekow ND, Pangon L, Brummer T, Molloy M, Hawkins NJ, Ward RL, Musgrove EA, Kohonen-Corish MR.

Anticancer Res. 2012 Jan;32(1):73-9.

PMID:
22213290
19.

The "Mutated in Colorectal Cancer" Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint.

Pangon L, Sigglekow ND, Larance M, Al-Sohaily S, Mladenova DN, Selinger CI, Musgrove EA, Kohonen-Corish MR.

Genes Cancer. 2010 Sep;1(9):917-26. doi: 10.1177/1947601910388937.

20.

Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.

Selinger CI, Cooper WA, Al-Sohaily S, Mladenova DN, Pangon L, Kennedy CW, McCaughan BC, Stirzaker C, Kohonen-Corish MR.

J Thorac Oncol. 2011 Jul;6(7):1179-89. doi: 10.1097/JTO.0b013e31821b4ce0.

Supplemental Content

Loading ...
Support Center